Holdings
Silverarc Capital Management, LLC
As of Jun 30, 2026, Silverarc Capital Management, LLC reported 58 positions worth US$771M. Largest: Celcuity Inc., Cogent Biosciences, Inc. and Immunome, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Celcuity Inc. | 501K | US$52.4M | +143K | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 1.28M | US$49.6M | −33,482 | Jun 30, 2026 |
| Immunome, Inc. | 2.02M | US$42.7M | +167K | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 390K | US$38M | −265K | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 311K | US$34.6M | +5,461 | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 353K | US$33.6M | +202K | Jun 30, 2026 |
| Monte Rosa Therapeutics, Inc. | 1.11M | US$26.8M | −894K | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.21M | US$26.5M | +325K | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 489K | US$24.8M | new | Jun 30, 2026 |
| Immunovant, Inc. | 619K | US$23.9M | +205K | Jun 30, 2026 |